Success Metrics

Active Trials
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_2
2
33%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting117%
unknown350%
not_yet_recruiting233%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruiting

Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases

NCT07638709
not_yet_recruitingphase_2

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

NCT07539753
unknownnot_applicable

Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

NCT06106997
recruitingphase_3

Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases

NCT05768490
unknownphase_2

The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC

NCT04193007
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07638709

Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases

Not Yet Recruiting
NCT07539753Phase 2

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

Not Yet Recruiting
NCT06106997Not Applicable

Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

Unknown
NCT05768490Phase 3

Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases

Recruiting
NCT04193007Phase 2

The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC

Unknown
NCT02544178

Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma

Unknown

All 6 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
6